4//SEC Filing
Nazzi Gianfranco 4
Accession 0001209191-21-015847
CIK 0000818686other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:07 PM ET
Size
11.8 KB
Accession
0001209191-21-015847
Insider Transaction Report
Form 4
Nazzi Gianfranco
EVP, Growth Markets Commercial
Transactions
- Exercise/Conversion
Ordinary Shares
2021-02-28+15,177→ 75,587.357 total - Sale
Ordinary Shares
2021-03-01$10.85/sh−15,177$164,684→ 60,410.357 total - Sale
Ordinary Shares
2021-03-01$10.88/sh−60,410.357$657,241→ 0 total - Exercise/Conversion
Restricted Share Units
2021-02-28−15,177→ 45,534 total→ Ordinary Shares (15,177 underlying)
Footnotes (6)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.775 to $11.005, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.84 to $10.91, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F6]Restricted share units were granted on February 28, 2020 with 15,177 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 15,180 vesting on February 28, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001725018
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:07 PM ET
- Size
- 11.8 KB